Applied DNA Sciences to Lead Panel and DNA Marking Workshop

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Applied DNA Sciences to Lead Panel and DNA Marking Workshop at ERAI Executive Conference

STONY BROOK, NY--(Marketwired - Apr 17, 2013) - Applied DNA Sciences, Inc . ( OTCBB : APDN ), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced today that senior managers will lead important meetings this week concerning the company's SigNature ® DNA marking program for electronics, currently required by the Defense Logistics Agency (DLA) for Federal Supply Class (FSC) 5962 microcircuits. The APDN SigNature DNA marking technology, which forensically protects against counterfeiting, has been gaining excitement and attention throughout the electronics industry. The platform will be explained by its most knowledgeable experts.

Janice Meraglia, Vice President of Government and Military Programs, and Bob MacDowell, Senior Sales Representative, will lead a workshop describing SigNature DNA marking. At a panel discussion focused on critical issues surrounding traceability in the supply chain, scheduled speakers are Dr. James A. Hayward, CEO and President of Applied DNA Sciences, Christine Metz, Chief of the Technical and Quality Policy Division for DLA Logistics Operations (Defense Logistics Agency), Tom Sharpe, Vice President of SMT Corp., Dave Loaney, CEO of Premier Semiconductor Service, and John Tomaszewicz, Quality Assurance Manager, Avnet USI. Please see below for time and place of these events.

"Signature DNA has been the subject of countless articles, meetings, blog posts and comments," observed Ms. Meraglia, "This is a chance to understand the platform factually and objectively, from the people who created it."

Applied DNA Sciences offers a botanical DNA taggant solution for the electronics industry that forensically prevents counterfeits from entering the supply chain. The U.S. Defense Logistics Agency clause 52.211-9074 requires SigNature DNA to be applied on all FSC 5962 microcircuits, which have been determined to be at high risk of counterfeiting. APDN also emphasizes the value of its SigNature DNA platform beyond the FSC 5962 category, including in other FSC classes and for commercial product. SigNature DNA marking adds a forensic layer of protection to the electronic component supply chain and complements existing best practices and accepted industry standards.

The ERAI Executive Conference is a noted forum for thought leaders in the electronics trades on supply chain subjects. Its theme for 2013 is: "Gaining Momentum - Supply Chain Advancements in the Fight Against Counterfeits." The two-day conference will include lectures, panel and round table discussions and interactive workshops led by subject matter experts from industry, government and academia.

Save the date!

ERAI Executive Conference April 18-19, 2013 Rosen Centre Hotel Orlando, Florida Panel: Traceability in the Age of Globalization

When: Thursday, April 18, 10:45 AM - 12:00 PM Who:

  • Dr. James A. Hayward, CEO and President of Applied DNA Sciences
  • Christine Metz, Chief of the Technical and Quality Policy division for DLA Logistics Operations (Defense Logistics Agency)
  • Tom Sharpe, Vice President of SMT Corp.
  • Dave Loaney, CEO of Premier Semiconductor Service
  • John Tomaszewicz, Quality Assurance Manager, Avnet USI.

Workshop: SigNature ® DNA Marking and Forensic Authentication of Electronic Components When: Thursday, April 18, 1:45 PM - 2:15 PM Who: Janice Meraglia and Bob MacDowell

About Applied DNA Sciences

APDN is a provider of botanical-DNA based security and authentication solutions that can help protect products, brands and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature ® DNA and smartDNA, our principal anti-counterfeiting and product authentication solutions that essentially cannot be copied, provide a forensic chain of evidence and can be used to prosecute perpetrators. 

The statements made by APDN may be forward-looking in nature. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K, filed on December 20, 2012 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.

MEDIA CONTACT: Mitchell Miller 646-543-3373 fax: 631-444-8848 INVESTOR CONTACT: Debbie Bailey 631-444-8090 fax: 631-444-8848 FCMN Contact: Email Contact Web site: http://www.adnas.com Twitter: @APDN, @APDNInvestor

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BIBIBOP Brings Good Vibes with OLIPOP Happy Hour

Updated Category News Views 131

Boosting Midday Energy with BIBIBOP's New Promo Here we go, folks. BIBIBOP Asian Grill is dialing up the culinary energy just when you need it most. From November 16 to 22, during their Good Energy Happy Hour, they’re serving up a deal designed to pump some pep into your afternoon—free OLIPOP prebiotic soda with any regular bowl purchase. Just stroll into any of their...

Continue Reading
Maritime Safety Urged After New Orleans Vessel Incident

Updated Category News Views 97

The Mississippi River saw a bit of drama near the Port of New Orleans when a river cruise turned into an unexpected rescue operation. Listen up, because incidents like this bring maritime safety right to the forefront; we can't ignore the waters that shape our daily lives here in the Big Easy. Navigating the Waters Safely Some 150 souls found themselves in a pickle when...

Continue Reading
Koppers Faces SEC Scrutiny After Earnings Miss

Updated Category News Views 169

Koppers' Third-Quarter Blues: Missing the Mark Koppers Holdings Inc. (NYSE: KOP) took a hard hit this quarter, missing Wall Street's earnings expectations by a mile. The adjusted earnings per share came in at just $0.77, while the suits down on Wall Street were expecting something closer to $1.34 to $1.37. Now, if you’re holding KOP in your portfolio, you're probably...

Continue Reading
Cardinal Infrastructure Faces Legal Scrutiny Amid Losses

Updated Category News Views 125

Cardinal Infrastructure Group Under Intense Investor Scrutiny Well, ain't this a messy soup of financial blunders? Cardinal Infrastructure Group (Nasdaq: CDNL) finds itself on the sharp end of a potential securities law investigation, thanks to some colossal screw-ups in managing project costs and estimates. Investors are rightly pissed after the company's shares...

Continue Reading
Biointron's RushDATA™: Speeding Up Antibody Discovery

Updated Category News Views 227

A New Chapter in Antibody Discovery Well, color me intrigued. Biointron, a name you'd recognize if you've got even a toe in the biotech pond, just threw a serious curveball into the antibody discovery game with RushDATA™—an AI- and machine learning-driven platform that's packing a punch. And it's not just about throwing tech buzzwords around; this thing clocks...

Continue Reading
Will Hair Loss Drugs Challenge Transplant Clinics?

Updated Category News Views 73

Emerging Treatments Stir Up Hair Loss Scene You ever get the feeling we're on the brink of something big? That's where we are with hair loss treatments, folks. As of late 2026, new drugs are making waves in clinical trials, but they’re not yet giving hair transplant clinics any sleepless nights. Smile Hair Clinic's co-founders, Dr. Mehmet Erdo?an and Dr. Gökay Bilgin,...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 137

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 108

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 219

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
Purdue's xGTT: Pioneering a New Trust Standard in Tech

Updated Category News Views 150

A Bold New Benchmark in Tech Trust You've got to hand it to the folks at Purdue's Krach Institute—they're not dancing around the fringes but diving straight into the thick of it with their Global Trusted Tech Standard, or xGTT. This isn't just another checkbox for compliance nerds. The xGTT is all about building trust in technology that's woven with democratic values...

Continue Reading

Top 5 Most Recently Viewed Articles

HawkEye 360 Expands Capabilities with Strategic NRO Partnership

Updated Category News Views 189

HawkEye 360's New Partnership with the NRO HawkEye 360, recognized as a leader in sharing signals intelligence data and analytics, has recently secured a significant funding extension from the National Reconnaissance Office (NRO) alongside the Commercial Systems Program Office (CSPO). This collaborative effort is set to span over 23 months, aiming to enhance the...

Continue Reading
Consumer Sentiment and Its Impact on Economic Reflation Trends

Updated Category News Views 88

Understanding Consumer Sentiment Trends In recent discussions, we have explored how indicators like inflation gauges can influence economic forecasts. A notable aspect is consumer sentiment, which provides insights into spending behaviors and overall market confidence. Recent readings suggest a surprising optimism among consumers, especially in light of complex inflation...

Continue Reading
Ocular Therapeutix Announces Major Stock Offering Ahead of Trials

Updated Category News Views 264

Ocular Therapeutix's Strategic Stock Offering Announcement Ocular Therapeutix, Inc. (Nasdaq: OCUL), known for its commitment to enhancing retinal health, has declared an exciting new chapter in its journey. The company has recently confirmed the pricing for an underwritten public offering of 37,909,018 shares of its common stock, set at $12.53 per share. This significant...

Continue Reading
Roku Ads Manager: Innovations for Today’s Marketing Landscape

Updated Category News Views 145

Roku Unveils Ads Manager for Growth-Driven Marketers Roku (NASDAQ: ROKU) has stepped up its game in the streaming industry by launching a new platform named Roku Ads Manager. This self-service tool is tailored specifically for marketers eager to improve their connected television (CTV) campaigns. The rollout of this innovative platform comes as advertising trends shift...

Continue Reading
Evaxion Secures $10.8 Million in Strategic Public Offering

Updated Category News Views 97

Evaxion Biotech's Recent Public Offering Evaxion Biotech A/S (NASDAQ: EVAX) has recently made headlines with its announcement of a public offering. The company, renowned for its pioneering work in AI-Immunology™, has set the offering's combined public price at $2.71 per ADS, with warrants allowing the purchase of equal representation. This promising move emphasizes...

Continue Reading